Contact O'Dwyer's: 271 Madison Ave., #600, New York, NY 10016; Tel: 212/679-2471; Fax: 212/683-2750
 
ODWYERPR.COM > Top Story return to main page

January 8, 2001

DRUG COMPANIES PUSHING CELEBRITY MESSAGE

 

Pharmaceutical companies are increasingly turning to a tactic that gets their drugs and the conditions they treat in the news--paying athletes and celebrities to tell reporters about their own struggles with illnesses, according to The Associated Press.

The campaign produces human interest stories that have raised some concern about the further blurring of the old line between news and commercial messages, reports Seth Sutel of the AP.

The recent campaigns have been aimed at the news sections of newspapers and TV, where personalities like former gymnast Bart Connor or former Olympic gold medalist skater Dorothy Hamill speak favorably about products for arthritis and other ailments.

Some of the celebrity appearances resemble public service campaigns about common and treatable medical conditions, such as high cholesterol, without referring to a specific drug the company makes to treat the condition. "In other cases, celebrities are hired to mention specific drugs in the interview," Sutel said.

Celeste Torello, who is manager of corporate media relations for Pfizer, told Sutel that the commercial relationship between the company and their celebrity hires is "made very clear to the journalists...It's really then up to the journalists to decide in the final story how much or how little of that relationship to mention."

In one such campaign, Connor was paid to discuss how he was treating his osteoarthritis with Celebrex, made by Pfizer and G.D. Searle & Co. Sutel said several news stories resulting from the campaign, including articles in The New York Daily News, AP and an appearance on ABC-TV's "Good Morning America," did not make clear that Connor was paid.

Todd Polkes, a spokesman for ABC, said his operation was unaware of Connor's relationship with Celebrex.

Ken Frydman, a Daily News spokesman, said his paper discourages promotion stories although he admitted once in a while a commercial reference finds its way into print.

Kelly Tunney, director of corporate communications for AP, said the news agency also questions the news value of such promotional stories.

In instances where an endorser's comments are judged newsworthy, Tunney said it is the reporter's responsibility to ask if he or she is paid by the manufacturer of the product and to include that information in the story.

Pfizer has also paid Julie Krone, a former top female jockey who retired last year after struggling with depression, to promote Zoloft, an anti-depressant she takes. Profiles of Krone and her struggles appeared in several news outlets.

Merck & Co., in another campaign, paid former athletes Bruce Jenner and Hamill to give interviews to news organizations last fall to discuss Vioxx, an anti-inflammatory medicine that they both use to treat arthritis. Several newspapers and TV news shows did stories on one or both of them.

Chris Fanelle, director of PA for the human health services division, said several sports celebrities were used in public education campaigns last year to raise awareness of health issues.

Fanelle said the media interviews with the celebrities were handled by Ogilvy PR Worldwide.

Other celebrities used in campaigns were coach Bill Parcells and quaterback Joe Montana for a high cholesterol awareness campaign; an osteoporosis campaign by actress Rita Moreno, and a campaign, featuring seven current major league baseball players, who used Propecia, a hair growing drug, for a year.

Atlanta Falcons coach Dan Reeves was also used as both an ad and PR spokesperson for a new heart drug.

Norm Ostrove, an official at the Food and Drug Administration's division of drug marketing, advertising and commercials, said the FDA has received no complaints about lack of disclosure by celebrities working as spokespeople.

 

Click here to e-mail this story to a friend

Click here to tell O'Dwyer's what you think about this story
(Responses, if any, are posted on this page.)

Responses:


 

Editorial Contacts | Order O'Dwyer Publications | Site Map

Copyright © 1998-2020 J.R. O'Dwyer Company, Inc.
271 Madison Ave., #600, New York, NY 10016; Tel: 212/679-2471